Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126526841 | 12652684 | 1 | I | 20150811 | 20150922 | 20160815 | 20160815 | PER | CA-PFIZER INC-3024573 | PFIZER | 64.00 | YR | F | Y | 0.00000 | 20160815 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126526841 | 12652684 | 1 | PS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | UNK | UNK | 11719 | ||||||||||
| 126526841 | 12652684 | 2 | SS | TOCILIZUMAB | TOCILIZUMAB | 1 | UNK | 0 | |||||||||||
| 126526841 | 12652684 | 3 | SS | ETANERCEPT | ETANERCEPT | 1 | UNK | 0 | |||||||||||
| 126526841 | 12652684 | 4 | SS | ABATACEPT | ABATACEPT | 1 | Intravenous (not otherwise specified) | UNK | 0 | ||||||||||
| 126526841 | 12652684 | 5 | C | ACETYLSALICYLIC ACID | ASPIRIN | 1 | 80 MG, FREQ: 1 DAY; INTERVAL: 1. | UNK | 0 | 80 | MG | ||||||||
| 126526841 | 12652684 | 6 | C | CELECOXIB. | CELECOXIB | 1 | 200 MG, FREQ: 2 DAY; INTERVAL:1. | UNK | 0 | 200 | MG | ||||||||
| 126526841 | 12652684 | 7 | C | TRAZODONE HYDROCHLORIDE. | TRAZODONE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 126526841 | 12652684 | 8 | C | BISOPROLOL FUMARATE. | BISOPROLOL FUMARATE | 1 | 2.5 MG, FREQ: 1 DAY; INTERVAL: 1. | UNK | 0 | 2.5 | MG | ||||||||
| 126526841 | 12652684 | 9 | C | PANTOPRAZOLE SODIUM SESQUIHYDRATE | PANTOPRAZOLE SODIUM | 1 | UNK | 0 | |||||||||||
| 126526841 | 12652684 | 10 | C | LEVOTHYROXINE SODIUM. | LEVOTHYROXINE SODIUM | 1 | UNK | 0 | |||||||||||
| 126526841 | 12652684 | 11 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 126526841 | 12652684 | 12 | C | ROSUVASTATINE | ROSUVASTATIN | 1 | UNK | 0 | |||||||||||
| 126526841 | 12652684 | 13 | C | TRAZODONE | TRAZODONE HYDROCHLORIDE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126526841 | 12652684 | 1 | Rheumatoid arthritis |
| 126526841 | 12652684 | 2 | Rheumatoid arthritis |
| 126526841 | 12652684 | 3 | Rheumatoid arthritis |
| 126526841 | 12652684 | 4 | Rheumatoid arthritis |
| 126526841 | 12652684 | 5 | Product used for unknown indication |
| 126526841 | 12652684 | 6 | Product used for unknown indication |
| 126526841 | 12652684 | 7 | Product used for unknown indication |
| 126526841 | 12652684 | 8 | Product used for unknown indication |
| 126526841 | 12652684 | 9 | Product used for unknown indication |
| 126526841 | 12652684 | 10 | Product used for unknown indication |
| 126526841 | 12652684 | 11 | Product used for unknown indication |
| 126526841 | 12652684 | 12 | Product used for unknown indication |
| 126526841 | 12652684 | 13 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126526841 | 12652684 | Drug ineffective | |
| 126526841 | 12652684 | Hepatic enzyme increased | |
| 126526841 | 12652684 | Malignant melanoma |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126526841 | 12652684 | 1 | 20150811 | 0 |